Stay updated on Pembrolizumab/Vibostolimab Combo in NSCLC Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab/Vibostolimab Combo in NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab/Vibostolimab Combo in NSCLC Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    The page's revision tag was updated from v3.6.3 to v3.6.4, indicating a new release of the site's interface or tooling.
    Difference
    0.0%
    Check dated 2026-07-28T15:12:52.000Z thumbnail image
  2. Check
    12 days ago
    No Change Detected
  3. Check
    19 days ago
    No Change Detected
  4. Check
    26 days ago
    No Change Detected
  5. Check
    33 days ago
    Change Detected
    Summary
    The page now shows a revision label updated from v3.6.0 to v3.6.3, indicating a recent update to the page framework. This change is an internal maintenance update and does not modify the study information presented.
    Difference
    0.0%
    Check dated 2026-06-30T05:46:32.000Z thumbnail image
  6. Check
    47 days ago
    Change Detected
    Summary
    The page now displays a recruitment-status note indicating that the study is no longer enrolling participants.
    Difference
    0.2%
    Check dated 2026-06-16T00:23:14.000Z thumbnail image
  7. Check
    54 days ago
    Change Detected
    Summary
    The page revision has been updated from v3.5.4 to v3.5.5, reflecting a minor metadata update rather than substantive changes to study details.
    Difference
    0.0%
    Check dated 2026-06-09T01:31:32.000Z thumbnail image
  8. Check
    76 days ago
    Change Detected
    Summary
    A new page revision tag, v3.5.4, was added and the previous v3.5.3 tag was removed, indicating a minor version update.
    Difference
    0.0%
    Check dated 2026-05-18T13:28:04.000Z thumbnail image
  9. Check
    97 days ago
    Change Detected
    Summary
    The page footer revision was updated from v3.5.2 to v3.5.3, reflecting a site release/update rather than any change to the study record details.
    Difference
    0.0%
    Check dated 2026-04-27T07:43:39.000Z thumbnail image

Stay in the know with updates to Pembrolizumab/Vibostolimab Combo in NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab/Vibostolimab Combo in NSCLC Clinical Trial page.